Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Third line anti-HIV therapy options

    Project Inform Perspective
    |May 4, 2004
    PubMed
    Summary
    This summary is machine-generated.

    Third line therapy, also known as salvage or rescue therapy, offers limited anti-HIV drug options for individuals with treatment failure or drug resistance. Understanding treatment failure is crucial for selecting future effective HIV drug combinations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same journal

    Everything antiretroviral: 5th IAS conference, Cape Town, South Africa.

    Project Inform perspective·2012
    Same journal

    Well implemented, President Obama's national HIV/AIDS strategy is precisely what is needed to further control HIV/AIDS.

    Project Inform perspective·2011
    Same journal

    Finding health care; preparing for the future.

    Project Inform perspective·2011
    Same journal

    Protecting people with HIV in the California budget.

    Project Inform perspective·2010
    Same journal

    Current drugs in clinical study.

    Project Inform perspective·2010
    Same journal

    HIV treatment information.

    Project Inform perspective·2010

    Area of Science:

    • Virology
    • Pharmacology
    • Immunology

    Background:

    • Third line therapy, or salvage therapy, is defined for patients with limited anti-HIV drug choices.
    • This approach is for individuals who have experienced treatment failure with at least two prior regimens or exhibit HIV resistance to key drug classes.

    Discussion:

    • Treatment failure in HIV management encompasses various reasons why a regimen may not be effective.
    • The specific causes of treatment failure dictate the potential re-use of individual drugs in subsequent combination therapies.

    Key Insights:

    • Salvage therapy addresses complex HIV treatment scenarios, including multi-drug resistance.
    • Identifying the precise reasons for prior regimen failure is essential for optimizing future HIV treatment strategies.

    Related Experiment Videos

    Outlook:

    • Further research into novel anti-HIV agents and resistance-breaking strategies is critical.
    • Personalized medicine approaches, guided by resistance profiles, will enhance salvage therapy effectiveness.